A synthetic nonsteroidal estrogen used in the treatment of menopausal and postmenopausal disorders. It was also used formerly as a growth promoter in animals. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), diethylstilbestrol has been listed as a known carcinogen.
Names & identifiers
Preferred name
Diethylstilbesterol
IUPAC
4-[4-(4-hydroxyphenyl)hex-3-en-3-yl]phenol
English name
Diethylstilbestrol
Molecular formula
C18H20O2
Molecular weight
268.35
Names & synonyms
RefChem:1083540Diethylstilbesterol6898-97-1(Z,E)-Diethylstilbestrolcis-Diethyl Stilbestrolalpha,alpha'-Diethyl-4,4'-stilbenediol-d4DTXSID3040770Phenol, 4,4'-(1,2-diethyl-1,2-ethenediyl)bis-Stilbestrol;DESStilbesterol, DESDESDiethylstilbestrol BP
Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Toxicology
Toxicity Summary · 1 item
Estrogens diffuse into their target cells and interact with a protein receptor, the estrogen receptor. Target cells include the female reproductive tract, the mammary gland, the hypothalamus, and the pituitary. The effect of Estrogen binding their receptors causes downstream increases the hepatic synthesis of sex hormone binding globulin (SHBG), thyroid-binding globulin (TBG), and other serum proteins and suppress follicle-stimulating hormone (FSH) from the anterior pituitary. The combination of an estrogen with a progestin suppresses the hypothalamic-pituitary system, decreasing the secretion of gonadotropin-releasing hormone (GnRH).
Signs and SymptomsSymptoms of overdose include nausea and vomiting, and withdrawal bleeding may occur in females.
Carcinogen Classification1, carcinogenic to humans. (L135)
Safety data
F
10
PPE
dust mask type N95 (US), Eyeshields, Gloves, type P2 (EN 143) respirator cartridges
wgk
3
tsca
TSCA listed
rtecs
WJ5600000
ridadr
UN 3077 9/PG 3
hs_code
29072990
Toxicity
LD50 oral in rat: > 3gm/kg
risk_code
45-61-36/37/38-51/53-40
Signal word
Danger
Symbol(GHS)
GHS07,GHS08,GHS09
hazard_code
T,N
safety_code
53-36/37/39-45-60-61-36/37
hazard_class
Chemistry & industry
Pharmacology
Metabolism/MetabolitesHepatic.
Cellular LocationsCytoplasm
Uses & manufacturing
UsesUsed in the treatment of prostate cancer. Previously used in the prevention of miscarriage or premature delivery in pregnant women prone to miscarriage or premature delivery.
Applications · 4 items
DescriptionDiethylstilbestrol (DES) is a synthetic estrogen receptor agonist that was prescribed to pregnant women in the late 1930s. It was banned in 1971 because of possible links to increased risk of breast cancer in mothers along with congenital abnormalities and increased risk of cancer in offspring. DES is structurally related to, and is as potent as, estradiol in most assays, with a longer half-life. It has a relative binding affinity to sex hormone binding globulin (SHBG) of 0.2 compared to estradiol which has a relative binding affinity of 100. A concentration of 20 μM DES, displaces 30 ± 13% of 3H-estradiol from SHBG in serum.
UsesDiethylstilbestrol has been used:to evaluate the estrogenic activity of diethylstilbestrol by quantitating the expression levels of endogenous estrogen-regulated marker genesto evaluate the estrogenic, androgenic and toxicity responses in bioluminescent yeast bioreporter assay (BLYES)to detect its effect on the proliferation and tyrosinase activity of melanocytes
UsesDiethylstilbestrol is a synthetic nonsteroidal estrogen that was formerly used in estrogenic hormone therapy (for menstrual disorders, postpartum breast engorgement, postcoital contraceptive, prevention of spontaneous abortion) and in chemotherapy of various cancers, including postmenopausal breast cancer and prostate cancer. It was also used in biomedical research and veterinary medicine (growth promoter for cattle and sheep; veterinary drug to treat estrogen deficiency disorders).
Diethylstilbestrol is an odorless tasteless white crystalline powder. (NTP, 1992)
DefinitionChEBI: Diethylstilbestrol is an olefinic compound that is trans-hex-3-ene in which the hydrogens at positions 3 and 4 have been replaced by p-hydroxyphenyl groups. It has a role as an antineoplastic agent, a carcinogenic agent, a xenoestrogen, an EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor, an antifungal agent, an endocrine disruptor, an EC 1.1.1.146 (11beta-hydroxysteroid dehydrogenase) inhibitor, an autophagy inducer and a calcium channel blocker. It is a polyphenol and an olefinic compound.